Sign up for a biotech newsletter to stay informed on the latest science and politics driving the industry. Keytruda celebrates ten years of success in cancer treatment, sparking debate on declaring patients cured. The psychedelics industry is growing with key players shaping the field for potential mental health treatments. Pfizer is exploring Medicare’s plan for digital treatments. Key Senate aide behind drug pricing policy is leaving, FDA formalizes protocol for international cancer trials. Recent study suggests Covid mRNA vaccines may boost cancer immunotherapy efficacy. Cardiovascular devices with safety recalls often not tested in patients.
Source link
Readout Newsletter: Keytruda, IRA, Pfizer, psychedelics
